Vaishali Sanchorawala, MD

Vaishali Sanchorawala is the Director of the Autologous Stem Cell Transplantation Program at Boston Medical Center and has been affiliated with the Amyloidosis Center of the Boston University School of Medicine since 1994 and recently has been appointed as Director of the Center. She has been one of the pioneers in the field of clinical research in AL amyloidosis and her work in the treatment of systemic AL amyloidosis has been published in many peer-reviewed journals, which has resulted in the evolution of the standard of care for patients.

Dr. Sanchorawala received her MBBS and postdoctoral training from the Seth G.S. Medical College, Bombay University, India, and completed her fellowship in hematology and oncology at Boston University Medical Center in 1997 when she joined Boston University School of Medicine as an Assistant Professor of Medicine and BMC as an attending physician. She was promoted to Associate Professor in 2005 and Professor in 2011.

Dr. Sanchorawala serves on the board of the International Society of Amyloidosis as an associate editor of Amyloid, Journal of Protein Folding Disorders, and as a member of the Executive Steering Committee of Amyloidosis Research Consortium. She has also participated in FDA meetings to enhance the amyloidosis drug development pathway for more effective treatments.

The Six-Minute Walk Test in Patients With Al Amyloidosis: A Single Centre Case Seriesexternal link, opens in a new tab

Depression and Anxiety in Patients With AL Amyloidosis as Assessed by the SF-36 Questionnaire: Experience in 1226 Patientsexternal link, opens in a new tab

Longitudinal Systolic Strain, Cardiac Function Improvement, and Survival Following Treatment of Light-Chain (AL) Cardiac Amyloidosisexternal link, opens in a new tab

Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosisexternal link, opens in a new tab